SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-078297
Filing Date
2022-03-17
Accepted
2022-03-17 16:06:28
Documents
6
Effectiveness Date
2022-03-17

Document Format Files

Seq Description Document Type Size
1 S-8 d280470ds8.htm S-8 31549
2 EX-5.1 d280470dex51.htm EX-5.1 5103
3 EX-23.1 d280470dex231.htm EX-23.1 1415
4 EX-FILING FEES d280470dexfilingfees.htm EX-FILING FEES 18388
5 GRAPHIC g280470dsp008.jpg GRAPHIC 16421
6 GRAPHIC g280470page5a.jpg GRAPHIC 8724
  Complete submission text file 0001193125-22-078297.txt   92596
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263638 | Film No.: 22748530
SIC: 2834 Pharmaceutical Preparations